(Q29041315)

7 August 2017

1 reference

title

Mice deficient in heparan sulfate 3-O-sulfotransferase-1: Normal hemostasis with unexpected perinatal phenotypes (English)

1 reference

27 March 2017

Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes (English)

1 reference

7 August 2017

Nicholas W. Shworak

1

1 reference

27 March 2017

Sassan HajMohammadi

2

2 references

27 March 2017

7 August 2017

Ariane I. de Agostini

3

1 reference

27 March 2017

Robert D. Rosenberg

4

1 reference

27 March 2017

Nicholas W Shworak

1

1 reference

7 August 2017

Ariane I de Agostini

3

1 reference

7 August 2017

Robert D Rosenberg

4

1 reference

7 August 2017

May 2002

1 reference

27 March 2017

1 May 2002

1 reference

7 August 2017

Glycoconjugate Journal

2 references

27 March 2017

7 August 2017

19

2 references

27 March 2017

7 August 2017

4/5

1 reference

27 March 2017

4-5

1 reference

7 August 2017

355-361

2 references

27 March 2017

Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan

7 August 2017

1 reference

12 December 2020

The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group

1 reference

12 December 2020

Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities

1 reference

12 December 2020

Anticoagulant Action of Heparin

1 reference

12 December 2020

Thrombophilia and fetal growth restriction

1 reference

12 December 2020

Experimental intrauterine growth retardation alters renal development

1 reference

12 December 2020

Effects of chronic reduction in uterine blood flow on fetal and placental growth in the sheep.

1 reference

12 December 2020

Contribution of monosaccharide residues in heparin binding to antithrombin III.

1 reference

12 December 2020

Characterization of a mouse model for thrombomodulin deficiency

1 reference

12 December 2020

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase

1 reference

12 December 2020

Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells

1 reference

12 December 2020

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state

1 reference

12 December 2020

Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology

1 reference

12 December 2020

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

1 reference

12 December 2020

Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition.

1 reference

12 December 2020

Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations

1 reference

12 December 2020

Characterization of a cell mutant specifically defective in the synthesis of anticoagulantly active heparan sulfate

1 reference

12 December 2020

Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence

1 reference

12 December 2020

Complete antithrombin deficiency in mice results in embryonic lethality

1 reference

12 December 2020

Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase

1 reference

12 December 2020

Anticoagulantly active heparin-like molecules from mast cell-deficient mice.

1 reference

12 December 2020

Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases.

1 reference

12 December 2020

Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells

1 reference

12 December 2020

Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line

1 reference

12 December 2020

Spontaneous thrombosis in mice carrying the factor V Leiden mutation

1 reference

12 December 2020

Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells

1 reference

12 December 2020

Superovulation-induced intrauterine growth retardation in mice

1 reference

12 December 2020

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

1 reference

12 December 2020

Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci

1 reference

12 December 2020

Hypercoagulability in venous and arterial thrombosis

1 reference

12 December 2020

Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi

1 reference

12 December 2020

Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool

1 reference

12 December 2020

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

12 December 2020

Antithrombin and its inherited deficiency states.

1 reference

12 December 2020

Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta

1 reference

12 December 2020

Vitronectin inhibits the thrombotic response to arterial injury in mice.

1 reference

12 December 2020

Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation

1 reference

12 December 2020

Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice

1 reference

12 December 2020

Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation

1 reference

12 December 2020

Spontaneous pup-killing by mice in response to large litters

1 reference

12 December 2020

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

1 reference

12 December 2020

Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells

1 reference

12 December 2020

Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate.

1 reference

12 December 2020

A murine model of myocardial microvascular thrombosis

1 reference

12 December 2020

Anticoagulant proteins in childhood venous and arterial thrombosis: a review

1 reference

12 December 2020

Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties

1 reference

12 December 2020

Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

Correlation between structure and function of heparin

1 reference

12 December 2020

Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025377206600

2 references

27 March 2017

Dimensions Publication ID

7 August 2017

1008061814

0 references

Fatcat ID

release_fs6sbr65tjh2jaww6mrwctqauy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fs6sbr65tjh2jaww6mrwctqauy

24 November 2022

mapped directly with Wikidata item

1 reference